Sponsor pipeline

Zhongda Hospital clinical trial pipeline

Get alerts when Zhongda Hospital's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-09-23 NCT07836309 TACE in Combination With Tislelizumab and Lenvatinib for Advanced HCC (CHANCE2602) Not Yet Recruiting

Active trials by phase

Early Phase 1
1
Phase 1/2
2
Not charted: 29 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials

Liver Cancer (12) · Cholangiocarcinoma (2) · Prostate Cancer (2) · Atopic Dermatitis (1) · Chronic Kidney Disease (1) · Depression (1) · Diabetes (1) · Heart Disease (1) · Heart Failure (1)

Get alerts when Zhongda Hospital's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free